Stopa primjene i ishod neoperativnog liječenja akutnog upala slijepog crijeva u okruženju COVID-19: sistematski pregled i meta-analiza.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
Sažetak istraživanja
Pozadina Neoperativno liječenje (NOM) akutnog upala slijepog crijeva procijenjeno je u nekoliko studija prije pandemije COVID-19. Ovaj sistematski pregled imao je za cilj procjenu obima usvajanja, efikasnosti i sigurnosti NOM-a akutnog upala slijepog crijeva u okruženju COVID-19.
Metode Ovo je bio sistematski pregled literature u skladu sa PRISMA-om. Elektronske baze podataka i Google Scholar su upitani za studije koje su primjenjivale NOM akutnog upala slijepog crijeva tokom COVID-19. Glavne mjere ishoda bile su stope primjene NOM-a tokom pandemije u odnosu na period prije pandemije, stope neuspjeha i komplikacija NOM-a. Neuspjeh je definiran kao potreba za uklanjanjem slijepog crijeva tokom NOM-a, a komplikacije su uključivale razvoj apendikularne mase ili apscesa.
Rezultati Uključeno je četrnaest studija (2140 pacijenata). Odnos muškaraca i žena bio je 1,44:1, a srednja starost je bila 34 godine. Devetsto pedeset i devet (44,8%) pacijenata je imalo ispitivanje NOM. Ponderisana srednja stopa primene NOM bila je 50,1% (95%CI: 29,8-70,5%). Primjena NOM-a tokom pandemije bila je značajno vjerojatnija od njegove primjene prije COVID-19 (OR = 6,7, p
Zaključak NOM akutnog upala slijepog crijeva u uvjetima COVID-19 može biti sigurna, kratkoročna alternativa operaciji s prihvatljivo niskim stopama neuspjeha i komplikacija.
Prikaži originalni naslov i sažetak na engleskom
Rate of Application and Outcome of Non-operative Management of Acute Appendicitis in the Setting of COVID-19: Systematic Review and Meta-analysis.
Background Non-operative management (NOM) of acute appendicitis has been assessed in several studies before COVID-19 pandemic. This systematic review aimed to assess the extent of adoption, efficacy, and safety of NOM of acute appendicitis in the setting of COVID-19.
Methods This was a PRISMA-compliant systematic review of the literature. Electronic databases and Google Scholar were queried for studies that applied NOM of acute appendicitis during COVID-19. The main outcome measures were the rates of NOM application during the pandemic as compared to the pre-pandemic period, failure and complication rates of NOM. Failure was defined as the need for appendectomy during NOM and complications included development of appendicular mass or abscess.
Results Fourteen studies (2140 patients) were included. The male to female ratio was 1.44:1 and median age was 34. Nine hundred fifty-nine (44.8%) patients had a trial of NOM. The weighted mean rate of NOM application was 50.1% (95%CI: 29.8-70.5%). The application of NOM during the pandemic was significantly more likely than its application before COVID-19 (OR = 6.7, p
Conclusion NOM of acute appendicitis in the setting of COVID-19 may be a safe, short-term alternative to surgery with acceptably low failure and complication rates.
Izvorni podaci
- DOI
- 10.1007/s11605-021-04988-1
- PMID
- 33772399
- PMCID
- PMC7997536
- Provjereno
- 2026-07-26
Naslov i sažetak prevedeni su automatski i prijevod može sadržavati netačnosti ili neprecizne stručne izraze. Za sve detalje, citiranje i medicinsko tumačenje pregledajte originalnu englesku verziju članka. Ne donosite zdravstvene odluke samo na osnovu ovog prijevoda.
Pregledaj originalni članak na engleskom